Surgical management of Parkinson’s disease

References

• Gillingham J. Forty-five years of stereotactic surgery for Parkinson’s disease: a review. Stereotact. Funct. Neurosurg.74(3–4), 95–98 (2000).
   Google Scholar
• Wycis HT, Spiegel EA. Ten years’ experience with stereotaxic operations on the basal ganglia. Clin. Neurosurg.6, 240–252 (1958).
   Google Scholar
• Guiot G, Brion S, Kerman M. Stereotaxic anatomy of the internal pallidum, of the thalamus and of the internal capsule. Studies of the individual variations II. Ann. Chir.15, 703–741 (1961).
   Google Scholar
• Svennilson E, Torvik A, Lowe R, Leksell L. Treatment of parkinsonism by stereotatic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr. Scand.35, 358–377 (1960).
   PubMed Web of Science ®Google Scholar
• Gillingham FJ, Watson WS, Donaldson AA, Naughton JA. The surgical treatment of parkinsonism. Br. Med. J.2(5210), 1395–1402 (1960).
   PubMedGoogle Scholar
• Laitinen LV. Personal memories of the history of stereotactic neurosurgery. Neurosurgery55(6), 1420–1428 (2004).
   Google Scholar
• Gildenberg PL. Evolution of basal ganglia surgery for movement disorders. Stereotact. Funct. Neurosurg.84(4), 131–135 (2006).
   Google Scholar
• Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism – chronic treatment with L-DOPA. N. Engl. J. Med.280(7), 337–345 (1969).
   PubMed Web of Science ®Google Scholar
• Hassler R, Riechert T, Mundinger F, Umbach W, Ganglberger JA. Physiological observations in stereotaxic operations in extrapyramidal motor disturbances. Brain83, 337–350 (1960).
   PubMed Web of Science ®Google Scholar
• Cooper IS. Clinical results and follow-up studies in a personal series of 300 operations for parkinsonism. J. Am. Geriatr. Soc.4(12), 1171–1181 (1956).
   PubMed Web of Science ®Google Scholar
• Laitinen LV, Bergenheim AT, Hariz MI. Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J. Neurosurg.76(1), 53–61 (1992).
   PubMed Web of Science ®Google Scholar
• de Bie RM, de Haan RJ, Nijssen PC et al. Unilateral pallidotomy in Parkinson’s disease: a randomised, single-blind, multicentre trial. Lancet354(9191), 1665–1669 (1999).
   PubMed Web of Science ®Google Scholar
• Vitek JL, Bakay RA, Freeman A et al. Randomized trial of pallidotomy versus medical therapy for Parkinson’s disease. Ann. Neurol.53(5), 558–569 (2003).
   PubMed Web of Science ®Google Scholar
• de Bie RM, Schuurman PR, Esselink RA, Bosch DA, Speelman JD. Bilateral pallidotomy in Parkinson’s disease: a retrospective study. Mov. Disord.17(3), 533–538 (2002).
   PubMed Web of Science ®Google Scholar
• Pollak P, Benabid AL, Gross C et al. Effects of the stimulation of the subthalamic nucleus in Parkinson disease. Rev. Neurol. (Paris)149(3), 175–176 (1993).
   PubMed Web of Science ®Google Scholar
• Limousin P, Pollak P, Benazzouz A et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet345(8942), 91–95 (1995).
   PubMed Web of Science ®Google Scholar
• de Rijk MC, Tzourio C, Breteler MM et al. Prevalence of parkinsonism and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry62(1), 10–15 (1997).
   PubMed Web of Science ®Google Scholar
• Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990. Neurology52(6), 1214–1220 (1999).
   PubMed Web of Science ®Google Scholar
• Braak H, Del TK, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging24(2), 197–211 (2003).
   PubMed Web of Science ®Google Scholar
• Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci.12(10), 366–375 (1989).
   PubMed Web of Science ®Google Scholar
• DeLong MR, Alexander GE, Georgopoulos AP, Crutcher MD, Mitchell SJ, Richardson RT. Role of basal ganglia in limb movements. Hum. Neurobiol.2(4), 235–244 (1984).
   PubMedGoogle Scholar
• Volkmann J, Sturm V, Weiss P et al. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson’s disease. Ann. Neurol.44(6), 953–961 (1998).
   PubMed Web of Science ®Google Scholar
• Krack P, Pollak P, Limousin P et al. Opposite motor effects of pallidal stimulation in Parkinson’s disease. Ann. Neurol.43(2), 180–192 (1998).
   PubMed Web of Science ®Google Scholar
• Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science249(4975), 1436–1438 (1990).
   PubMed Web of Science ®Google Scholar
• Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov. Disord.6(4), 288–292 (1991).
   PubMed Web of Science ®Google Scholar
• Benazzouz A, Gross C, Feger J, Boraud T, Bioulac B. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci.5(4), 382–389 (1993).
   PubMed Web of Science ®Google Scholar
• Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson’s disease: networks, models and treatments. Trends Neurosci.30(7), 357–364 (2007).
   PubMed Web of Science ®Google Scholar
• Brown P, Williams D. Basal ganglia local field potential activity: character and functional significance in the human. Clin. Neurophysiol.116(11), 2510–2519 (2005).
   PubMed Web of Science ®Google Scholar
• Krack P, Limousin P, Benabid AL, Pollak P. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson’s disease. Lancet350(9092), 1676 (1997).
   PubMed Web of Science ®Google Scholar
• Limousin P, Krack P, Pollak P et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N. Engl. J. Med.339(16), 1105–1111 (1998).
   PubMed Web of Science ®Google Scholar
• Krack P, Batir A, van Blercom N et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N. Engl. J. Med.349(20), 1925–1934 (2003).
   PubMed Web of Science ®Google Scholar
• Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. Long-term outcome of 50 consecutive Parkinson’s disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat. Disord.14(2), 114–119 (2008).
   PubMed Web of Science ®Google Scholar
• Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med.355(9), 896–908 (2006).
   PubMed Web of Science ®Google Scholar
• Derost PP, Ouchchane L, Morand D et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology68(17), 1345–1355 (2007).
   PubMed Web of Science ®Google Scholar
• Voon V, Krack P, Lang AE et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain131(Pt 10), 2720–2728 (2008).
   PubMed Web of Science ®Google Scholar
• Hariz MI, Johansson F, Shamsgovara P, Johansson E, Hariz GM, Fagerlund M. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Mov. Disord.15(1), 136–139 (2000).
   PubMed Web of Science ®Google Scholar
• Tripoliti E, Zrinzo L, Martinez-Torres I et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov. Disord.23(16), 2377–2383 (2008).
   PubMedGoogle Scholar
• Brown RG, Jahanshahi M. Cognitive-motor dysfunction in Parkinson’s disease. Eur. Neurol.36(Suppl. 1), 24–31 (1996).
   Google Scholar
• Hariz MI, Krack P, Melvill R et al. A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact. Funct. Neurosurg.80(1–4), 96–101 (2003).
   PubMed Web of Science ®Google Scholar
• Deep Brain Stimulation Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N. Engl. J. Med.345(13), 956–963 (2001).
   PubMed Web of Science ®Google Scholar
• Zrinzo L. The role of imaging in the surgical treatment of movement disorders. Neuroimaging Clin. N. Am.20(1), 125–140 (2010).
   Google Scholar
• Tagliati M, Jankovic J, Pagan F, Susatia F, Isaias IU, Okun MS. Safety of MRI in patients with implanted deep brain stimulation devices. Neuroimage47(Suppl. 2), T53–T57 (2009).
   PubMed Web of Science ®Google Scholar
• Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. Postoperative management of subthalamic nucleus stimulation for Parkinson’s disease. Mov. Disord.17(Suppl. 3), S188–S197 (2002).
   Google Scholar
• Volkmann J, Moro E, Pahwa R. Basic algorithms for the programming of deep brain stimulation in Parkinson’s disease. Mov. Disord.21(Suppl. 14), S284–S289 (2006).
   PubMed Web of Science ®Google Scholar
• Witt K, Daniels C, Reiff J et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol.7(7), 605–614 (2008).
   PubMed Web of Science ®Google Scholar
• Hariz MI, Johansson F. Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency. Mov. Disord.16(1), 166–168 (2001).
   PubMed Web of Science ®Google Scholar
• Czernecki V, Schupbach M, Yaici S et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov. Disord.23(7), 964–969 (2008).
   PubMed Web of Science ®Google Scholar
• Hilker R, Portman AT, Voges J et al. Disease progression continues in patients with advanced Parkinson’s disease and effective subthalamic nucleus stimulation. J. Neurol. Neurosurg. Psychiatry76(9), 1217–1221 (2005).
   PubMed Web of Science ®Google Scholar
• Bejjani BP, Jabre M, Nohra G. The new phenotype of Parkinson’s disease: the post-subthalamic stimulation era. Neurology70(Suppl. 1) A179 (2008).
   Google Scholar
• Schupbach WM, Maltete D, Houeto JL et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology68(4), 267–271 (2007).
   PubMed Web of Science ®Google Scholar
• Schuurman PR, Bosch DA, Bossuyt PM et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N. Engl. J. Med.342(7), 461–468 (2000).
   PubMed Web of Science ®Google Scholar
• Schuurman PR, Bosch DA, Merkus MP, Speelman JD. Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression. Mov. Disord.23(8), 1146–1153 (2008).
   PubMed Web of Science ®Google Scholar
• Hariz MI, Krack P, Alesch F et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J. Neurol. Neurosurg. Psychiatry79(6), 694–699 (2008).
   PubMed Web of Science ®Google Scholar
• Woods SP, Fields JA, Lyons KE et al. Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson’s disease: a one-year follow-up. Acta Neurochir. (Wien.)143(12), 1273–1277 (2001).
   PubMed Web of Science ®Google Scholar
• Hariz MI, Shamsgovara P, Johansson F, Hariz G, Fodstad H. Tolerance and tremor rebound following long-term chronic thalamic stimulation for Parkinsonian and essential tremor. Stereotact. Funct. Neurosurg.72(2–4), 208–218 (1999).
   PubMed Web of Science ®Google Scholar
• Limousin P, Speelman JD, Gielen F, Janssens M. Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J. Neurol. Neurosurg. Psychiatry66(3), 289–296 (1999).
   PubMed Web of Science ®Google Scholar
• Pahwa R, Lyons KE, Wilkinson SB et al. Long-term evaluation of deep brain stimulation of the thalamus. J. Neurosurg.104(4), 506–512 (2006).
   PubMed Web of Science ®Google Scholar
• Krack P, Pollak P, Limousin P, Hoffmann D, Benazzouz A, Benabid AL. Inhibition of levodopa effects by internal pallidal stimulation. Mov. Disord.13(4), 648–652 (1998).
   PubMed Web of Science ®Google Scholar
• Krack P, Pollak P, Limousin P et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson’s disease. Brain121(Pt 3), 451–457 (1998).
   PubMed Web of Science ®Google Scholar
• Rodriguez-Oroz MC, Obeso JA, Lang AE et al. Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain128(Pt 10), 2240–2249 (2005).
   PubMed Web of Science ®Google Scholar
• Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology56(4), 548–551 (2001).
   PubMed Web of Science ®Google Scholar
• Volkmann J, Allert N, Voges J, Sturm V, Schnitzler A, Freund HJ. Long-term results of bilateral pallidal stimulation in Parkinson’s disease. Ann. Neurol.55(6), 871–875 (2004).
   PubMed Web of Science ®Google Scholar
• Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch. Neurol.62(4), 554–560 (2005).
   PubMed Web of Science ®Google Scholar
• Moro E, Lozano AM, Pollak P et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov. Disord.25(5), 578–586 (2010).
   PubMed Web of Science ®Google Scholar
• Zahodne LB, Okun MS, Foote KD et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J. Neurol.256(8), 1321–1329 (2009).
   PubMed Web of Science ®Google Scholar
• Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J. Impact of STN-DBS on life and health satisfaction in patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry81(3), 315–319 (2010).
   PubMed Web of Science ®Google Scholar
• Volkmann J, Albanese A, Kulisevsky J et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson’s disease. Mov. Disord.24(8), 1154–1161 (2009).
   PubMed Web of Science ®Google Scholar
• Weaver FM, Follett K, Stern M et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA301(1), 63–73 (2009).
   PubMed Web of Science ®Google Scholar
• Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C. Multicenter study on deep brain stimulation in Parkinson’s disease: an independent assessment of reported adverse events at 4 years. Mov. Disord.23(3), 416–421 (2008).
   PubMed Web of Science ®Google Scholar
• Alvarez L, Macias R, Pavón N et al. Therapeutic efficacy of unilateral subthalamotomy in Parkinson’s disease: results in 89 patients followed for up to 36 months. J. Neurol. Neurosurg. Psychiatry80(9), 979–985 (2009).
   PubMed Web of Science ®Google Scholar
• Zrinzo L, Zrinzo LV. Surgical anatomy of the pedunculopontine and peripeduncular nuclei. Br. J. Neurosurg.22(Suppl. 1), S19–S24 (2008).
   PubMedGoogle Scholar
• Jenkinson N, Nandi D, Oram R, Stein JF, Aziz TZ. Pedunculopontine nucleus electric stimulation alleviates akinesia independently of dopaminergic mechanisms. Neuroreport17(6), 639–641 (2006).
   PubMed Web of Science ®Google Scholar
• Plaha P, Gill SS. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson’s disease. Neuroreport16(17), 1883–1887 (2005).
   PubMed Web of Science ®Google Scholar
• Ferraye MU, Debu B, Fraix V et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson’s disease. Brain133(Pt 1), 205–214 (2009).
   Google Scholar
• Mazzone P, Lozano A, Stanzione P et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson’s disease. Neuroreport16(17), 1877–1881 (2005).
   PubMed Web of Science ®Google Scholar
• Krauss JK, Pohle T, Weigel R, Burgunder J-M. Deep brain stimulation of the centre median-parafascicular complex in patients with movement disorders. J. Neurol. Neurosurg. Psychiatry72, 546–548 (2002).
   PubMed Web of Science ®Google Scholar
• Plaha P, Ben-Shlomo Y, Patel NK, Gill SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain129, 1732–1747 (2006).
   PubMed Web of Science ®Google Scholar
• Blomstedt P, Sandvik U, Fytagoridis A, Tisch S. The posterior subthalamic area in the treatment of movement disorders: past, present, and future. Neurosurgery64(6), 1029–1042 (2009).
   PubMed Web of Science ®Google Scholar
• Marks WJ Jr, Ostrem JL, Verhagen L et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson’s disease: an open-label, Phase I trial. Lancet Neurol.7(5), 400–408 (2008).
   PubMed Web of Science ®Google Scholar
• Christine CW, Starr PA, Larson PS et al. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology73(20), 1662–1669 (2009).
   PubMed Web of Science ®Google Scholar
• Hovland DN Jr, Boyd RB, Butt MT et al. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys. Toxicol. Pathol.35(7), 1013–1029 (2007).
   PubMed Web of Science ®Google Scholar
• Kaplitt MG, Feigin A, Tang C et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: an open label, Phase I trial. Lancet369(9579), 2097–2105 (2007).
   PubMed Web of Science ®Google Scholar
• Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med.344(10), 710–719 (2001).
   PubMed Web of Science ®Google Scholar
• Olanow CW, Freeman T, Kordower J. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med.345(2), 146 (2001).
   Google Scholar
• Kleiner-Fisman G, Herzog J, Fisman DN et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov. Disord.21(Suppl. 14), S290–S304 (2006).
   PubMed Web of Science ®Google Scholar
• Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J. Neurol. Neurosurg. Psychiatry76(9), 1188–1193 (2005).
   PubMed Web of Science ®Google Scholar
• Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J. Neurosurg.103(6), 956–967 (2005).
   PubMed Web of Science ®Google Scholar
• Videnovic A, Metman LV. Deep brain stimulation for Parkinson’s disease: prevalence of adverse events and need for standardized reporting. Mov. Disord.23(3), 343–349 (2008).
   PubMed Web of Science ®Google Scholar